Why is BCG a vaccine against TB getting so much hype during the COVID-19 pandemic? This webinar features talks by Prof Christine Benn on “BCG for COVID-19 – hope or hype?” & Prof Gerhard Walz on “BCG trials for COVID-19 in SA – progress and promise.” Both talks discuss how BCG may have non-specific effects against other infections, and how it could be used to potentially reduce the incidence of COVID-19 before an approved efficacious COVID-19 vaccine is available.
Related Posts
